Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Role of neuroinflammation in neurodegenerative diseases (Review).
Correction to Imidazol-1-ylethylindazole Voltage-Gated Sodium Channel Ligands Are Neuroprotective during Optic Neuritis in a Mouse Model of Multiple Sclerosis.
Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats.
Effects of beta 2 adrenergic agonists on axonal injury and mitochondrial metabolism in experimental autoimmune encephalomyelitis rats.
Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease.
Label-free imaging to study phenotypic behavioural traits of cells in complex co-cultures.
Multiple sclerosis in Japan appears to be a milder disease compared to the UK.
Medications Are Associated with Falls in People with Multiple Sclerosis: A Prospective Cohort Study.
Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.
Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis.
Acute-Phase Protein Hemopexin Is a Negative Regulator of Th17 Response and Experimental Autoimmune Encephalomyelitis Development.
Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures.
Surface-based analysis reveals regions of reduced cortical magnetization transfer ratio in patients with multiple sclerosis: A proposed method for imaging subpial demyelination.
Development of a cross-cultural item bank for measuring quality of life related to mental health in multiple sclerosis patients.
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis.
The contribution of optical coherence tomography in neurodegenerative diseases.
A urological challenge: Voiding dysfunction in multiple sclerosis.
SNPsea: an algorithm to identify cell types, tissues, and pathways affected by risk loci.
Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS.
The role of clinical and instrumented outcome measures in balance control of individuals with multiple sclerosis.
Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry.
The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life.
Social support and depressive symptoms among caregivers of veterans with multiple sclerosis.
Stable biomarker for plastic microglia.
[Treatment of multiple sclerosis: new approaches to treat case by case].

Pages